Publications


ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer;
Gorur, A, Bayraktar, R, Ivan, C, Mokhlis, HA, Bayraktar, E, Kahraman, N, Karakas, D, Karamil, S, Kabil, NN, Kanlikilicer, P, Aslan, B, Tamer, L, Wang, Z, Cristini, V, Lopez-Berestein, G, Calin, G & Ozpolat, B 2021, , Molecular Therapy - Nucleic Acids, vol. 23, pp. 930-943. https://doi.org/10.1016/j.omtn.2021.01.016

Erratum: A multiscale Agent-Based Model of Ductal Carcinoma in Situ (IEEE Trans. Biomed. Eng (2020) 67: 5 (1450-1461) DOI: 10.1109/TBME.2019.2938485);
Butner, JD, Fuentes, D, Ozpolat, B, Calin, GA, Zhou, X, Lowengrub, J, Cristini, V & Wang, Z 2021, , IEEE Transactions on Biomedical Engineering, vol. 68, no. 2, 9331330. https://doi.org/10.1109/TBME.2020.3044508

A mathematical model for the quantification of a patient’s sensitivity to checkpoint inhibitors and long-term tumour burden;
Butner, JD, Wang, Z, Elganainy, D, Al Feghali, KA, Plodinec, M, Calin, GA, Dogra, P, Nizzero, S, Ruiz-Ramírez, J, Martin, GV, Tawbi, HA, Chung, C, Koay, EJ, Welsh, JW, Hong, DS & Cristini, V 2021, , Nature Biomedical Engineering. https://doi.org/10.1038/s41551-020-00662-0

Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model;
Dogra, P, Ruiz-Ramírez, J, Sinha, K, Butner, JD, Peláez, MJ, Rawat, M, Yellepeddi, VK, Pasqualini, R, Arap, W, Sostman, HD, Cristini, V & Wang, Z 2021, , ACS Pharmacology and Translational Science, vol. 4, no. 1, pp. 248-265. https://doi.org/10.1021/acsptsci.0c00183

A mathematical model to estimate chemotherapy concentration at the tumor-site and predict therapy response in colorectal cancer patients with liver metastases;
Anaya, DA, Dogra, P, Wang, Z, Haider, M, Ehab, J, Jeong, DK, Ghayouri, M, Lauwers, GY, Thomas, K, Kim, R, Butner, JD, Nizzero, S, Ramírez, JR, Plodinec, M, Sidman, RL, Cavenee, WK, Pasqualini, R, Arap, W, Fleming, JB & Cristini, V 2021, , Cancers, vol. 13, no. 3, 444, pp. 1-18. https://doi.org/10.3390/cancers13030444

Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection;
Zaid, M, Elganainy, D, Dogra, P, Dai, A, Widmann, L, Fernandes, P, Wang, Z, Pelaez, MJ, Ramirez, JR, Singhi, AD, Dasyam, AK, Brand, RE, Park, WG, Rahmanuddin, S, Rosenthal, MH, Wolpin, BM, Khalaf, N, Goel, A, Von Hoff, DD, Tamm, EP, Maitra, A, Cristini, V & Koay, EJ 2020, , Frontiers in Oncology, vol. 10, 596931. https://doi.org/10.3389/fonc.2020.596931

Pharmacological activity and cancer theranostic applications of lipid-coated silica nanoparticles;
Dogra, P, Butner, J, Cristini, V & Wang, Z 2020, . in M Saravanan & H Barabadi (eds), Cancer Nanotheranostics. Nanotechnology in the Life Sciences, Springer.

Imaging-based subtypes of pancreatic ductal adenocarcinoma exhibit differential growth and metabolic patterns in the pre-diagnostic period: implications for early detection;
Staquicini, D, Barbu, E, Zemans, R, Dray, B, Staquicini, F, Dogra, P, Wang, Z, Cristini, V, Sidman, RL, Berman, A, Tuder, R, Pasqualini, R & Arap, W 2020, , Med.

A mechanistic immunotherapy model provides patient-specific quantification of immune response and associated long-term tumor burden;
Butner, J, Wang, Z, Elganainy, D, Plodinec, M, Calin, GA, Dogra, P, Nizzero, S, Ruiz Ramírez, J, Chung, C, Koay, EJ, Welsh, J, Hong, DS & Cristini, V 2020, , Nature Biomedical Engineering.

Imaging-based subtypes of pancreatic ductal adenocarcinoma exhibit differential growth and metabolic patterns in the pre-diagnostic period: implications for early detection;
Zaid, M, Elganainy, D, Dogra, P, Dai, A, Fernandes, P, Wang, Z, Peláez, MJ, Ruiz Ramírez, J, Singhi, AD, Brand, RE, Tamm, EP, Cristini, V & Koay, EJ 2020, , Frontiers in Oncology. https://doi.org/10.3389/fonc.2020.596931